» Articles » PMID: 38949502

To Boldly Go into Molecular Endotypes of Bronchiectasis Exacerbations

Overview
Specialty Critical Care
Date 2024 Jul 1
PMID 38949502
Authors
Affiliations
Soon will be listed here.
References
1.
Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M . Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023; 11(7):637-649. DOI: 10.1016/S2213-2600(23)00093-0. View

2.
Choi H, Ryu S, Keir H, Giam Y, Dicker A, Perea L . Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med. 2023; 208(11):1166-1176. DOI: 10.1164/rccm.202303-0499OC. View

3.
Hill A, Haworth C, Aliberti S, Barker A, Blasi F, Boersma W . Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017; 49(6). DOI: 10.1183/13993003.00051-2017. View

4.
Aksamit T, Locantore N, Addrizzo-Harris D, Ali J, Barker A, Basavaraj A . Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Am J Respir Crit Care Med. 2024; 210(1):108-118. DOI: 10.1164/rccm.202307-1165OC. View

5.
Gao Y, Richardson H, Dicker A, Barton A, Kuzmanova E, Shteinberg M . Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study. Am J Respir Crit Care Med. 2024; 210(1):77-86. DOI: 10.1164/rccm.202310-1729OC. View